Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 29-04-2024
Project: RESCEU
Updated at: 25-02-2023
Project: RESCEU
Updated at: 25-02-2023